Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...